DMCC Speciality Chemicals Q1 FY27 profit jumps 163%

Q1 FY27 result: sharp rise in profit and income

DMCC Speciality Chemicals Ltd (NSE: DMCC) reported a strong set of numbers for the quarter ended June 30, 2026 (Q1 FY27). The company said standalone net profit rose to ₹20.41 crore, compared with ₹7.75 crore in the same quarter last year. Standalone income from operations also increased sharply to ₹252.99 crore from ₹127.02 crore a year ago.

The Q1 update was shared with stock exchanges on August 10, 2026, after the board approved the unaudited financial results. The company also filed limited review reports from its statutory auditors. For investors, the headline takeaways were the steep year-on-year expansion in profit and the near-doubling of income.

Key reported numbers (standalone)

On a standalone basis, DMCC Speciality Chemicals reported:

• Net profit of ₹20.41 crore in Q1 FY27 versus ₹7.75 crore in Q1 FY26
• Income from operations of ₹252.99 crore versus ₹127.02 crore
• Basic and diluted EPS of ₹8.18 for the quarter

Another quarterly summary included operational profitability metrics, showing operating margin (OPM) of 13.49% in the June 2026 quarter versus 13.29% in the June 2025 quarter. The same summary reported PBDT at ₹30.94 crore (versus ₹15.23 crore) and PBT at ₹27.21 crore (versus ₹11.03 crore).

Consolidated performance and subsidiary consolidation

On a consolidated basis, DMCC Speciality Chemicals reported net profit of ₹20.40 crore for the quarter. The consolidated results incorporate DMCC (Europe) GMBH as the sole subsidiary.

The statutory auditors noted that they did not review the interim financial results of the subsidiary. For the quarter ended June 2026, the subsidiary reported total revenues of ₹0.0164 crore (₹1.64 lakh), a net loss after tax of ₹0.0007 crore (₹0.07 lakh), and other comprehensive income of ₹-0.0076 crore (₹-0.76 lakh). The subsidiary numbers were included based on management-furnished unaudited statements, as described in the filing.

Board meeting: timing and approvals

The company informed exchanges that its Board of Directors met on August 10, 2026. The meeting commenced at 12:30 p.m. IST and concluded at 2:55 p.m. IST. During this meeting, the board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

The approval and disclosure were made under Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Along with the financial results, the board also took on record the limited review reports from the statutory auditors.

Auditor review: unmodified limited review opinion

The statutory auditors, Rahul Gautam Divan and Associates, issued an unmodified limited review opinion on both the standalone and consolidated financial statements. In practical terms, an unmodified conclusion indicates the reviewers did not identify material misstatements in the information reviewed, based on the limited review procedures.

This point was specifically highlighted in the disclosure, which may matter to investors tracking governance signals around quarterly reporting, especially when results are unaudited and subject to limited review rather than a full audit.

Notes on multiple public summaries and reconciliation

The information circulating alongside the exchange filing included multiple financial summaries. One summary stated that for Q1 FY27, revenue was ₹233 crore (₹2.33 billion) with EBITDA of ₹23 crore (₹0.23 billion) and PAT of ₹20 crore (₹0.20 billion).

At the same time, the company’s standalone income from operations was reported as ₹252.99 crore for the quarter, compared with ₹127.02 crore in the prior-year quarter. Where different summaries show different totals, investors typically need to reconcile line items such as “revenue”, “sales”, “income from operations”, and “total income” using the original filing PDF available on the exchange portal.

Trading window closure dates

The company also disclosed trading-window restrictions under the SEBI (Prohibition of Insider Trading) Regulations, 2015 and its internal code. The trading window for dealing in the company’s securities was to remain closed until 48 hours after the outcome of the board meeting.

As stated, the trading window would remain closed until August 12, 2026 and re-open on August 13, 2026.

Stock references cited alongside results

The material also carried market references for the stock, including a cited share price of ₹277.65 in one place. Another snapshot mentioned a CMP of ₹253, a market capitalisation of ₹620 crore, and a P/E described as “not meaningful”. These figures were presented as contextual data points and may vary by timestamp and source.

Summary table: key facts from the filing and result note

Market impact: what changed for investors this quarter

The biggest market-relevant signal in the disclosed numbers is the gap between this year’s and last year’s quarterly profit and income. A move from ₹7.75 crore to ₹20.41 crore in standalone net profit changes near-term earnings visibility, and the reported EPS of ₹8.18 provides a clearer per-share picture for Q1.

The unmodified limited review opinion is another data point investors track during results season, since it indicates the statutory auditors did not flag material issues in the limited review. The disclosure also clarifies how the consolidated results treat the subsidiary, including the fact that the subsidiary’s interim numbers were not reviewed by the group auditor.

Analysis: why the disclosure matters

This results update is also a compliance event. The company disclosed board approval timing, regulatory references (Regulations 30 and 33), and the limited review outcome, all of which are part of how quarterly reporting is assessed by the market.

The presence of multiple result summaries with different topline numbers underscores the importance of using exchange filings as the primary reference. For readers comparing “sales”, “revenue”, and “income from operations”, the differences can materially change conclusions about growth rates.

Conclusion

DMCC Speciality Chemicals’ Q1 FY27 filing showed standalone net profit rising to ₹20.41 crore on income from operations of ₹252.99 crore, alongside an unmodified limited review opinion from the statutory auditors. The board approved the results on August 10, 2026, and the trading window was stated to re-open on August 13, 2026. Investors tracking the stock will likely focus next on the detailed schedules in the exchange PDF and subsequent quarterly updates for consistency in reported line items.